- Title
- The pharmacotherapeutic treatment of attention-deficit/hyperactivity disorder (ADHD) in children and adolescents
- Creator
- Oettle, Judith Ann Elizabeth
- Subject
- Attention-deficit hyperactivity disorder -- Treatment -- South Africa
- Subject
- Attention-deficit hyperactivity disorder -- Alternative treatment -- South Africa
- Subject
- Attention-deficit-disordered children -- Treatment -- South Africa
- Subject
- Attention-deficit disorder in adolescence -- Treatment -- South Africa
- Subject
- Drug utilization -- South Africa
- Date Issued
- 2010
- Date
- 2010
- Type
- Thesis
- Type
- Masters
- Type
- MPharm
- Identifier
- vital:10134
- Identifier
- http://hdl.handle.net/10948/1438
- Identifier
- Attention-deficit hyperactivity disorder -- Treatment -- South Africa
- Identifier
- Attention-deficit hyperactivity disorder -- Alternative treatment -- South Africa
- Identifier
- Attention-deficit-disordered children -- Treatment -- South Africa
- Identifier
- Attention-deficit disorder in adolescence -- Treatment -- South Africa
- Identifier
- Drug utilization -- South Africa
- Description
- Background: The ideal treatment of Attention-Deficit/Hyperactivity Disorder is a highly debated issue. Opposition to pharmacological treatments has resulted in the popular use of non-pharmacological measures which are not necessarily efficacious for the management of ADHD. Objectives: The primary aim was to evaluate the treatment of children and adolescents diagnosed with ADHD in South Africa. Methods: The study consisted of two parts, a drug utilisation review (DUR) and questionnaire-based surveys. The DUR was conducted using a database containing central nervous system (CNS) drug prescriptions which were dispensed during 2008. A total of 21 650 prescriptions dispensed to 7 202 patients constituted the Primary study population which was analysed. The questionnaires were distributed to the parents/caregivers of children diagnosed with ADHD. A response rate of 20.81 percent was obtained. Results: The average age of patients in the DUR was 11.60 ±3.01 years. Male patients represented 74.09 percent (5 336: n = 7 202) of patients. Methylphenidate was the most commonly prescribed of the two drugs indicated for the treatment of ADHD (85.89 percent, 18 956: n = 21 650). A prescribing bias by practitioners in different parts of South Africa was identified. Drug holidays were identified during March and December of 2008. The average age of patients in the questionnaire was 10.67 ±2.83 years, with a male patient majority (86.11 percent, 31: n = 36). Methylphenidate was the most commonly used prescription treatment (93.75 percent, 30: n = 32). Drug holiday use was reported in 56.25 percent (18: n = 32) of patients. Most participants reported supplement use (83.33 percent, 30: n = 36), but 86.67 percent (26: n = 30) of these participants did not find them useful. Conclusion: ADHD is a poorly understood disorder which affects people in all spheres of life. Treatment of the disorder should be individualised and based on scientifically proven effectiveness. Further studies, both in South Africa and worldwide, need to be conducted on the treatment of ADHD
- Format
- xiv, 303 leaves : col. ill. ; 31 cm
- Format
- Publisher
- Nelson Mandela Metropolitan University
- Publisher
- Faculty of Health Sciences
- Language
- English
- Rights
- Nelson Mandela Metropolitan University
- Hits: 822
- Visitors: 1033
- Downloads: 254
Collections
NMMU School of Medicinal Sciences
| Thumbnail | File | Description | Size | Format | |||
|---|---|---|---|---|---|---|---|
| View Details Download | SOURCEPDF | 6 MB | Adobe Acrobat PDF | View Details Download |